Founded in 1994, EnzyMed, Inc. is currently a privately held research services company that specializes in the discovery, optimization, and derivitization of pharmaceutical and agrochemical compounds utilizing its combinatorial biocatalysis platform. EnzyMed's unique approach integrates iterative enzymatic and microbial reactions with selected chemical synthesis to both expand upon and complement traditional medicinal and combinatorial chemistry. In combination with its automated components, the technology has proven itself applicable to small molecules, natural products, and large synthetic lead compounds.
Founded in 1995, IRORI is a leading developer of combinatorial chemistry systems designed to accelerate drug discovery and the identification of novel compounds. The Company has formed collaborations with Bristol Myers Squibb and Rhône-Poulenc Rorer (custom combinatorial chemistry systems), DuPont Pharmaceuticals (drug discovery), and Hewlett Packard (drug discovery technology). IRORI is a wholly owned subsidiary of Discovery Partners International. It is headquartered in La Jolla, California and its IRORI Europe Ltd. office is located near Manchester, England.
Otava provides the synthesis of compounds within a particular class of molecules selected by the customer. We have a chemical synthesis expertise in a wide range of drug discovery fields and can offer the production of compounds with exclusive or non-exclusive agreements (up to 100 grams). We also offer derivatization of various heterocyclic compounds, pharmacophores and small molecules.
Senomyx, Inc., is a company focused on using taste receptor-based assays and screening technologies to discover and develop flavors, flavor enhancers and taste modulators for the packaged food, beverage and ingredient industries. It licenses its flavor ingredients to its collaborators on an exclusive or co-exclusive basis. The Company has entered into product discovery and development collaborations with seven packaged food and beverage companies, which include Ajinomoto Co., Inc. (Ajinomoto), Cadbury Schweppes (Cadbury), Campbell Soup Company (Campbell), The Coca-Cola Company (Coca-Cola), Firmenich SA (Firmenich), Nestle SA (Nestle) and Solae LLC (Solae). Senomyx’s programs focus on the development of savory, sweet and salt flavor enhancers, high potency sweeteners, bitter blockers and cooling agents. The Company is pursuing the discovery and development of flavor ingredients through six programs focused on savory, sweet, salt, bitter and cooling taste areas. (Source: 10-K)
Albany Molecular Research, Inc. provides scientific services, technologies and products. The Company's core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing, and a separate, stand-alone research and development division consisting of technology investments, internal drug discovery and niche generic active pharmaceutical ingredient product development. With locations in the United States, Europe and Asia, the Company provides customers with a range of services and cost models. (Source: 10-K)
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory